Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Oct 15, 2020; 12(10): 1195-1208
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1195
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1195
Figure 1 Blood exosomal microRNA profiling in hepatocellular carcinoma patients and non-hepatocellular carcinoma patients.
The top 5 principal components of blood exosomal micro RNA profiles from hepatocellular carcinoma (HCC) patients and non-HCC patients are shown. The red represents HCC patients, and the green represents non-HCC patients. HCC: Hepatocellular carcinoma.
Figure 2 Daily alcohol consumption alters the blood exosomal microribonucleic acid profiles of hepatitis B virus positive non-hepatocellular carcinoma patients.
A: Distribution of daily alcohol drinkers and non-daily alcohol drinkers on principal components 1 (PC1) and PC2; B: Distribution of PC1 weight and PC2 weight of each microRNA; C and D: Expression level comparisons of miR-3168 (C) and miR-223-3p (D) from daily alcohol drinkers and non-daily alcohol drinkers between hepatocellular carcinoma patients and non-hepatocellular carcinoma patients are demonstrated. HCC: Hepatocellular carcinoma.
Figure 3 Blood exosomal micro ribonucleic acid profiles reveal the stage of tumor tissues.
A: Distribution of hepatocellular carcinoma patients with stage A, stage B, and stage C on principal components 1 (PC1) and PC2. The yellow represents the patients with stage A, the blue represents the patients with stage B, and the red represents the patients with stage C; B: Histogram displaying PC1 scores of patients with stage A, stage B, and stage C. The histogram color is labeled as in A; C: Distribution of PC1 weight and PC2 weight of each micro ribonucleic acid. The colorindicates the hazardous levels based on The Cancer Genome Atlas data; D: Kaplan–Meier analysis of overall survival of two groups (high expression and low expression of miR-455-5p); E: Kaplan–Meier analysis of overall survival of the two groups (high expression and low expression of miR-30c-5p).
Figure 4 Accuracy of biomarkers from blood exosomal micro ribonucleic acid to classify hepatocellular carcinoma and non-hepatocellular carcinoma patients is affected by tumor stage and alcohol consumption habits.
A: The area under the curve of paired exosomal micro ribonucleic acid in cohort 1 and cohort 2; B: Distribution of the two paired blood exosomal miRNAs (miR-628-3p/miR-941 and miR-584-5p/miR-106-3p) colored according to tumor stage; and C: Alcohol consumption habits. HCC: Hepatocellular carcinoma.
- Citation: Sheng LQ, Li JR, Qin H, Liu L, Zhang DD, Zhang Q, Huang ML, Li XL, Xu XY, Wei YN, Chen ZS, Luo H, Zhang JY, Zhou CH, Chen H, Chen ZG, Li FG, Li NF. Blood exosomal micro ribonucleic acid profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers for differential diagnosis. World J Gastrointest Oncol 2020; 12(10): 1195-1208
- URL: https://www.wjgnet.com/1948-5204/full/v12/i10/1195.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i10.1195